Publications

YKVN partners Diep Hoai Nam, Duong Thu Ha, Vu Dzung and Nguyen Thu Hang share their insights on current M&A developments and recent transactions in Vietnam in the Vietnam chapter of the 2021 [...]

This newsletter provides a brief overview of the mandatory standards of producing Gx1 and Gx2 drugs, and Vietnam’s tender regulations governing these packages, with a short discussion on the [...]

The 2021 IFLR Mergers & Acquisitions Report brings sharp international and country perspectives on M&A trends in the global pandemic period. YKVN’s partners, Truong Nhat Quang, Le Thi Loc, and [...]

The “Healthcare Law Review” is a comprehensive annual global healthcare-focused legal report that brings law experts analysis and insights from the most significant jurisdictions worldwide. It is [...]

Our Vietnam litigation practice has received widespread professional recognition in the region for the team’s outstanding work. Our partners Truong Trong Nghia, Truong Nhat Quang, counsel Nguyen [...]

COVID-19 is raising the issue on the extension of market access to some critical life-saving and life-extending drugs. In this Newsletter, we provide a broad picture of the situation and make [...]

The business operation has been slowing down since the start of the diseases initially detected and spread in Wuhan, China. In Vietnam, the Government has adopted strong measures with the aim to [...]

Following the outbreak of the new strain of virus, Covid-19, the world has been put on a pause since the start of the diseases initially dedicated and spread in Wuhan, China.   On March 11, [...]

Private equity has blossomed in Vietnam in recent years, fueled by dramatic economic growth coupled with increasing interest in Vietnam as an investment destination. Our partner Phan Vinh Nhan [...]

Vietnam’s economy has enjoyed significant growth over the past decades. In parallel with the country’s growth, huge investments have been made into the infrastructure and the energy sector of the [...]